Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
163 participants
INTERVENTIONAL
2012-10-31
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The delayed usual care reflects the usual treatment practice in Hong Kong
* The early intensive care includes tight monitoring and immediate adjustment of therapy
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early RA Vascular Randomised Controlled Study
NCT01768923
Effects of Achieving SDAI Remission on Joint Space Outcomes Progression in Early Rheumatoid Arthritis: an HR-pQCT Study
NCT04324892
Finding Early Rheumatoid Arthritis
NCT01341314
An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis
NCT01656278
The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary Study
NCT01050010
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual care group
Usual care
Usual care
Usual care is defined as treatment decision at the discretion of the rheumatologists and patients reflecting daily clinical practice
Intensive care group
Protocolized intensive treatment
Protocolized intensive treatment
Intensive treatment is defined as early diagnosis, frequent assessment (monthly) of disease activity that guides treatment change with the aim to achieve clinical remission based on a tight control protocol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Protocolized intensive treatment
Intensive treatment is defined as early diagnosis, frequent assessment (monthly) of disease activity that guides treatment change with the aim to achieve clinical remission based on a tight control protocol
Usual care
Usual care is defined as treatment decision at the discretion of the rheumatologists and patients reflecting daily clinical practice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with at least 1 tender and swollen joint
* duration of symptoms less than 2 years
* no previous use of DMARDs
For intensive care group:
* patients with at least 1 tender and swollen joint
* duration of symptoms less than 2 years
* no previous use of DMARDs
* patients who fulfill the 2010 ACR/EULAR classification criteria for RA
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lai-Shan Tam
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lai Shan Tam, MD
Role: PRINCIPAL_INVESTIGATOR
Chinese University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prince of Wales Hospital
Hong Kong, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERA-MRI-2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.